132 related articles for article (PubMed ID: 5756534)
1. [Effect of 5-mercapto-6-azauracil and cysteine on the toxicity of cyclophosphamide].
Timar M; Vrejoiu G; Teodorescu M; Eneskcu L
Farmakol Toksikol; 1968; 31(6):741-2. PubMed ID: 5756534
[No Abstract] [Full Text] [Related]
2. [Mechanism of action of 5-mercapto-6-azauracil].
Timar M; Gedrikh I; Vrezhoiu G; Peushesku E
Farmakol Toksikol; 1969; 32(5):602-4. PubMed ID: 5395562
[No Abstract] [Full Text] [Related]
3. 6-azauracil derivative as liver function test in the course of cyclophosphamide treatment.
Timar M; Hädrich I; Banu E; Nitelea I; Teodorescu M
Farmaco Prat; 1967 Jul; 22(7):403-9. PubMed ID: 5632982
[No Abstract] [Full Text] [Related]
4. [Effect of various aminothiol compounds on the toxicity and specific activity of antitumor preparations].
Spasskaia IG; Iurchenko NIa; Rachinskiĭ FIu
Vopr Onkol; 1968; 14(10):75-9. PubMed ID: 5724801
[No Abstract] [Full Text] [Related]
5. [Influence of pretreatment with cyclophosphamide, ribo-azauracil and mercaleukin on experimental metastases in a syngeneic tumour-host-system: II. Chemically induced sarcomas of mouse and rat].
Elbe B; Nowak C; Arnold W; Bender E
Arch Geschwulstforsch; 1973; 41(2):137-45. PubMed ID: 4800210
[No Abstract] [Full Text] [Related]
6. Opposite effect of miltefosine on the antineoplastic activity and haematological toxicity of cyclophosphamide.
Stekar J; Hilgard P; Klenner T
Eur J Cancer; 1995; 31A(3):372-4. PubMed ID: 7786605
[TBL] [Abstract][Full Text] [Related]
7. [The protective effect of AET, cystamine and cystaphos when using lethal doses of antineoplastic drugs].
Larionov LF; Spasskaia IG
Vopr Onkol; 1968; 14(12):33-9. PubMed ID: 5714181
[No Abstract] [Full Text] [Related]
8. [Kinetic growth curves of sarcoma 45 treated with alkylating agents].
Kiseleva EG; Bogdanov GN; Konovalova NP; Emanuél' NM
Izv Akad Nauk SSSR Biol; 1970; 4():530-4. PubMed ID: 5482749
[No Abstract] [Full Text] [Related]
9. [Dynamics of toxic manifestations and antineoplastic effect of dactinomycin after single-dose administration].
Lupinosov IuV; Syrkin AB
Antibiotiki; 1971 Jan; 16(1):63-7. PubMed ID: 5553278
[No Abstract] [Full Text] [Related]
10. [The use of cystophos in experimental chemotherapy of tumors].
Aliev RG
Vopr Onkol; 1966; 12(8):86-90. PubMed ID: 6002133
[No Abstract] [Full Text] [Related]
11. [Extract of Eleutherococcus senticosus maxim and the therapeutic activity of cyclophosphane, ethymidine, and benzo-TEPA].
Monakhov BV
Vopr Onkol; 1967; 13(8):94-7. PubMed ID: 5601555
[No Abstract] [Full Text] [Related]
12. [The leukocyte count as a criterion of toxicity in combined administration of ionizing rays and cytostatic substances].
Fleischmann E; Karrer K
Strahlentherapie; 1966 Aug; 130(4):586-9. PubMed ID: 5996858
[No Abstract] [Full Text] [Related]
13. Chemoprotection against cyclophosphamide-induced urotoxicity: comparison of nine thiol protective agents.
Roberts JC; Francetic DJ; Zera RT
Anticancer Res; 1994; 14(2A):389-95. PubMed ID: 8017838
[TBL] [Abstract][Full Text] [Related]
14. [Reconstitution of cyclophosphamide-induced, impaired function of the immune system in animal models].
Artym J
Postepy Hig Med Dosw; 2003; 57(1):55-66. PubMed ID: 12765123
[TBL] [Abstract][Full Text] [Related]
15. Protective effect of triterpenoid fractions from the rhizomes of Astilbe chinensis on cyclophosphamide-induced toxicity in tumor-bearing mice.
Sun HX; Peng XY
J Ethnopharmacol; 2008 Sep; 119(2):312-7. PubMed ID: 18692125
[TBL] [Abstract][Full Text] [Related]
16. [Comparative study of the side effects of embikhin, sarcolysin and asalin].
Sof'ina ZP
Farmakol Toksikol; 1969; 32(3):312-6. PubMed ID: 5810949
[No Abstract] [Full Text] [Related]
17. [Effect of toxic doses of antineoplastic agents on cellular composition of porous connective tissue of mice].
Rozenberg IB
Farmakol Toksikol; 1970; 33(2):212-6. PubMed ID: 5425631
[No Abstract] [Full Text] [Related]
18. [Animal experimental for the evaluation of hematopoietic system reactivity following cytostatic load using the adrenaline and pyraside test].
Schmidt W; Morczek A; Wichert H
Radiobiol Radiother (Berl); 1972; 13(1):93-103. PubMed ID: 5035446
[No Abstract] [Full Text] [Related]
19. [Intracavitary chemotherapy of S 180 ascites sarcoma in mice with 4-(S-ethanol)-sulfido-cyclophosphamide in combination with protector thiols].
Voelcker G; Jaschke A; Wrabetz E; Hohorst HJ
Arzneimittelforschung; 1984; 34(10):1291-8. PubMed ID: 6440565
[TBL] [Abstract][Full Text] [Related]
20. [Comparison of ifosfamid with cyclophosphamide in the therapy of rat DS carcinosarcoma].
von Ardenne M; Reitnauer PG; Rohde K
Arch Geschwulstforsch; 1971; 38(1):15-26. PubMed ID: 4334130
[No Abstract] [Full Text] [Related]
[Next] [New Search]
